Inovio Pharmaceuticals, Inc. SEC filings INO
Inovio Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 20, 2008. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 2, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 6, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 31, 2026 | Jul 29, 2026 |
| 424B5 | Prospectus supplement | Jul 30, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 424B5 | Prospectus supplement | Jul 29, 2026 | — |
| EFFECT | Filing | Jul 10, 2026 | — |
| S-3 | Shelf registration | Jul 2, 2026 | — |
| S-8 | Employee stock plan registration | May 26, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 20, 2026 | May 19, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 20, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 6, 2026 | Apr 2, 2026 |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 2, 2026 | Apr 1, 2026 |
| 424B5 | Prospectus supplement | Apr 2, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 424B5 | Prospectus supplement | Jan 27, 2026 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 29, 2025 | Dec 29, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 12, 2025 | Nov 11, 2025 |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 7, 2025 | Jul 2, 2025 |
| 424B5 | Prospectus supplement | Jul 3, 2025 | — |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 22, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 7, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 7, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 16, 2024 | Dec 12, 2024 |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 424B5 | Prospectus supplement | Aug 13, 2024 | — |
| 8-K |
Current report
Material agreement
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 28, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 17, 2024 | Apr 15, 2024 |
| 424B5 | Prospectus supplement | Apr 17, 2024 | — |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 11, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 6, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Jan 31, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| S-3/A | Filing | Jan 26, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 25, 2024 | Jan 24, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 12, 2024 | Jan 12, 2024 |
| DEF 14A | Proxy statement | Nov 28, 2023 | Jan 12, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 17, 2023 | Jan 12, 2024 |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| S-3 | Shelf registration | Nov 9, 2023 | — |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Listing notice
|
Nov 2, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Exit or restructuring costs
|
Aug 1, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 23, 2023 | Jun 23, 2023 |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| S-8 | Employee stock plan registration | May 18, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 18, 2023 | May 16, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| EFFECT | Filing | Apr 3, 2023 | — |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| ARS | Annual report to shareholders | Mar 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Mar 28, 2023 | Dec 31, 2022 |
| POS EX | Filing | Mar 28, 2023 | — |
| POS AM | Filing | Mar 1, 2023 | — |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| POSASR | Filing | Mar 1, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 1, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
Jan 31, 2023 | Jan 18, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| UPLOAD | Letter from the SEC | Oct 14, 2022 | — |
| CORRESP | Letter to the SEC | Sep 29, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2022 | — |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Jul 19, 2022 | Jul 18, 2022 |
| S-8 | Employee stock plan registration | Jun 30, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 17, 2022 | May 16, 2022 |
| DEFA14A | Additional proxy material | May 11, 2022 | — |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
May 10, 2022 | May 9, 2022 |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEF 14A | Proxy statement | Mar 25, 2022 | May 16, 2022 |
| S-8 | Employee stock plan registration | Mar 1, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 424B5 | Prospectus supplement | Nov 9, 2021 | — |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Agreement ended
|
Oct 29, 2021 | Oct 28, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2021 | Oct 26, 2021 |
| 10-Q | Quarterly report | Aug 9, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 11, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
May 17, 2021 | May 13, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| DEF 14A | Proxy statement | Mar 25, 2021 | Dec 31, 2020 |
| S-8 | Employee stock plan registration | Mar 1, 2021 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 1, 2021 | Mar 1, 2021 |
| 10-K | Annual report | Mar 1, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 22, 2021 | Jan 20, 2021 |
| 424B5 | Prospectus supplement | Jan 22, 2021 | — |
| 8-K |
Current report
Results of operations, Other events
|
Jan 20, 2021 | Jan 20, 2021 |
| 424B5 | Prospectus supplement | Jan 20, 2021 | — |
| S-3ASR | Automatic shelf registration | Jan 20, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 4, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Nov 16, 2020 | Nov 16, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Agreement ended
|
Oct 15, 2020 | Oct 9, 2020 |
| 8-K |
Current report
Other events
|
Sep 28, 2020 | Sep 25, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2020 | Aug 28, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jun 25, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Other events
|
Jun 3, 2020 | Jun 3, 2020 |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2020 | May 14, 2020 |
| 8-K |
Current report
Other events
|
May 12, 2020 | May 12, 2020 |
| 424B5 | Prospectus supplement | May 12, 2020 | — |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| UPLOAD | Letter from the SEC | May 1, 2020 | — |
| CORRESP | Letter to the SEC | Apr 24, 2020 | — |
| DEFA14A | Additional proxy material | Apr 15, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2020 | — |
| 8-K |
Current report
Other events
|
Apr 6, 2020 | Apr 6, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 3, 2020 | Apr 3, 2020 |
| 424B5 | Prospectus supplement | Apr 3, 2020 | — |
| EFFECT | Filing | Mar 31, 2020 | — |
| CORRESP | Letter to the SEC | Mar 27, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | Dec 31, 2019 |
| UPLOAD | Letter from the SEC | Mar 23, 2020 | — |
| S-3 | Shelf registration | Mar 13, 2020 | — |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 424B5 | Prospectus supplement | Mar 9, 2020 | — |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Mar 9, 2020 | Mar 3, 2020 |
| EFFECT | Filing | Feb 13, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2020 | — |
| CORRESP | Letter to the SEC | Feb 10, 2020 | — |
| 424B5 | Prospectus supplement | Feb 7, 2020 | — |
| 8-K |
Current report
Material agreement
|
Feb 7, 2020 | Feb 7, 2020 |
| S-3 | Shelf registration | Jan 31, 2020 | — |
| S-8 | Employee stock plan registration | Jan 31, 2020 | — |
| D | Filing | Jan 24, 2020 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 15, 2020 | Jan 15, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 2, 2020 | Dec 26, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| D | Filing | Aug 15, 2019 | — |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
|
Aug 6, 2019 | Jul 31, 2019 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Jul 16, 2019 | Jul 12, 2019 |
| 8-K |
Current report
Other events
|
Jun 4, 2019 | Jun 3, 2019 |
| S-8 | Employee stock plan registration | May 31, 2019 | — |
| 8-K |
Current report
Other events
|
May 28, 2019 | May 28, 2019 |
| 8-K |
Current report
Other events
|
May 21, 2019 | May 21, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 10, 2019 | May 8, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| DEF 14A | Proxy statement | Mar 25, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 25, 2019 | Mar 21, 2019 |
| S-8 | Employee stock plan registration | Mar 15, 2019 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 12, 2019 | Mar 6, 2019 |
| 10-K | Annual report | Mar 12, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 26, 2019 | Feb 21, 2019 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Feb 20, 2019 | Feb 13, 2019 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 13, 2019 | Feb 13, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 3, 2019 | Jan 1, 2019 |
| 10-Q | Quarterly report | Nov 8, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 7, 2018 | Jun 30, 2018 |
| 424B5 | Prospectus supplement | Jun 11, 2018 | — |
| EFFECT | Filing | Jun 8, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2018 | — |
| CORRESP | Letter to the SEC | Jun 6, 2018 | — |
| S-3 | Shelf registration | May 25, 2018 | — |
| 8-K |
Current report
Material agreement
|
May 25, 2018 | May 25, 2018 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2018 | May 11, 2018 |
| 10-Q | Quarterly report | May 9, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Other events
|
Apr 13, 2018 | Apr 11, 2018 |
| CT ORDER | Filing | Mar 30, 2018 | — |
| DEF 14A | Proxy statement | Mar 28, 2018 | May 11, 2018 |
| S-8 | Employee stock plan registration | Mar 19, 2018 | — |
| 10-K | Annual report | Mar 14, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Other events
|
Jan 8, 2018 | Dec 28, 2017 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jan 2, 2018 | Dec 28, 2017 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 6, 2017 | Dec 5, 2017 |
| 10-Q | Quarterly report | Nov 8, 2017 | Sep 30, 2017 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Plymouth Meeting, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1055726
- Former names
- INOVIO BIOMEDICAL CORP (until May 11, 2010); GENETRONICS BIOMEDICAL CORP (until Apr 1, 2005); GENETRONICS BIOMEDICAL LTD (until Aug 3, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.